FDA Peptide Reclassification 2026: The Peptide Renaissance and What it Means for You
The FDA peptide reclassification 2026 is a game-changer. Key peptides are moving from Category 2 to Category 1, signaling a new era for therapeutic access. What does this mean for patients and the future of health science?
June 2, 20265 min read
Read Article ›